CTLA4 antibody (AA 110-223)
Quick Overview for CTLA4 antibody (AA 110-223) (ABIN7599734)
Target
See all CTLA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 110-223
 - 
                                            
Purpose
 - Anti-CTLA4 Antibody
 - 
                                            
Cross-Reactivity (Details)
 - No cross-reactivity with other proteins.
 - 
                                            
Characteristics
 - Anti-CTLA4 Antibody Picoband® (ABIN7599734). Tested in ELISA, IHC applications. This antibody reacts with Human.
 - 
                                            
Purification
 - Immunogen affinity purified.
 - 
                                            
Immunogen
 - E.coli-derived human CTLA4 recombinant protein (Position: N110-N223).
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        Immunohistochemistry (Paraffin-embedded Section), 2-5 μg/mL, Human
ELISA, 0.1-0.5 μg/mL, -
1. Dariavach P, Mattéi MG, Golstein P, Lefranc MP (December 1988). "Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains". Eur. J. Immunol. 18 (12): 1901-5. 2. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y (November 1999). "A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells".Eur. J. Immunol. 29 (11): 3596-602. 3. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW (November 1995). "Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4". Science 270(5238): 985-8. - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Reconstitution
 - Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
 - 
                                            
Concentration
 - 500 μg/mL
 - 
                                            
Buffer
 - Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 
                        Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. 
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. 
 - 
                                            
 - 
    
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
 - 
                                            
Alternative Name
 - CTLA4
 - 
                                            
Background
 - 
                        
Synonyms: Cytotoxic T-lymphocyte protein 4,Cytotoxic T-lymphocyte-associated antigen 4,CTLA-4,CD152,Ctla4,Cd152,
Tissue Specificity: Widely expressed with highest levels in lymphoid tissues. .
Background: CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4), also known as CD152, is a protein receptor that down regulates the immune system. It is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Blockade of CTLA4 expression in vitro augmented HIV-specific CD4-positive T-cell function.
 - 
                                            
Molecular Weight
 - 25 kDa
 - 
                                            
Gene ID
 - 1493
 - 
                                            
UniProt
 - P16410
 - 
                                            
Pathways
 - Cancer Immune Checkpoints
 
Target
 -